The securities fraud class action has been dismissed by a US District Judge. Plaintiffs claimed the company defrauded investors about the internal safety concerns about its anti inflammatory medications. (Feb-28-05)
[BOSTON BUSINESS NEWS
If you have a similar problem and would like to be contacted by a lawyer at no obligation, please fill in our form on the right
to submit your complaint.